These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 15951696)
1. Calcium iodate-another effective blocker of radioiodine uptake by the thyroid gland. Pahuja DN; Jagtap VS; Sonawane VR; Rajan MG; Samuel AM Health Phys; 2005 Jul; 89(1):92-4. PubMed ID: 15951696 [TBL] [Abstract][Full Text] [Related]
2. Potassium iodate and its comparison to potassium iodide as a blocker of 131I uptake by the thyroid in rats. Pahuja DN; Rajan MG; Borkar AV; Samuel AM Health Phys; 1993 Nov; 65(5):545-9. PubMed ID: 8225995 [TBL] [Abstract][Full Text] [Related]
3. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone. Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259 [TBL] [Abstract][Full Text] [Related]
4. Thyroid blockade during a radiation emergency in iodine-rich areas: effect of a stable-iodine dosage. Takamura N; Nakamura Y; Ishigaki K; Ishigaki J; Mine M; Aoyagi K; Yamashita S J Radiat Res; 2004 Jun; 45(2):201-4. PubMed ID: 15304961 [TBL] [Abstract][Full Text] [Related]
5. Effects of high potassium iodate intake on iodine metabolism and antioxidant capacity in rats. Li X; Cao X; Li J; Xu J; Ma W; Wang H; Wang J; Zhang Y J Trace Elem Med Biol; 2020 Dec; 62():126575. PubMed ID: 32580100 [TBL] [Abstract][Full Text] [Related]
6. Effects of time of administration and dietary iodine levels on potassium iodide (KI) blockade of thyroid irradiation by 131I from radioactive fallout. Zanzonico PB; Becker DV Health Phys; 2000 Jun; 78(6):660-7. PubMed ID: 10832925 [TBL] [Abstract][Full Text] [Related]
7. Histamine Receptor 1 and 2 Antagonists Alter Biodistribution of Radioiodine. Edwards O; Yakish ED; Wang LM; Wu Q; Hoffman JM; Morton KA J Nucl Med Technol; 2015 Sep; 43(3):214-9. PubMed ID: 26111706 [TBL] [Abstract][Full Text] [Related]
8. A gamma camera re-evaluation of potassium iodide blocking efficiency in mice. Hammond WT; Bradley EL; Welsh RE; Qian J; Weisenberger AG; Smith MF; Majewski S; Saha MS Health Phys; 2007 Apr; 92(4):396-406. PubMed ID: 17351505 [TBL] [Abstract][Full Text] [Related]
9. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer. de Keizer B; Hoekstra A; Konijnenberg MW; de Vos F; Lambert B; van Rijk PP; Lips CJ; de Klerk JM J Nucl Med; 2004 Sep; 45(9):1549-54. PubMed ID: 15347723 [TBL] [Abstract][Full Text] [Related]
10. Internal exposure monitoring of 131I-radiopharmaceutical production workers in Iran. Alirezazadeh N; Garshasbi H; Karimi Diba J Radiat Prot Dosimetry; 2003; 104(2):173-6. PubMed ID: 12918795 [TBL] [Abstract][Full Text] [Related]
11. Thyroid uptake and radiation dose after (131)I-lipiodol treatment: is thyroid blocking by potassium iodide necessary? Bacher K; Brans B; Monsieurs M; De Winter F; Dierckx RA; Thierens H Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1311-6. PubMed ID: 12271412 [TBL] [Abstract][Full Text] [Related]
12. Analysis of potassium iodate reduction in tissue homogenates using high performance liquid chromatography-inductively coupled plasma-mass spectrometry. Cao X; Ma W; Liu L; Xu J; Wang H; Li X; Wang J; Zhang J; Wang Z; Gu Y J Trace Elem Med Biol; 2015 Oct; 32():1-6. PubMed ID: 26302905 [TBL] [Abstract][Full Text] [Related]
13. Effect of furosemide on radioiodine-131 retention in mice thyroid gland. Matovic MD; Jankovic SM; Jeremic M; Novakovic M; Milosev M; Vlajkovic M Hell J Nucl Med; 2009; 12(2):129-31. PubMed ID: 19675865 [TBL] [Abstract][Full Text] [Related]
14. Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients. Canzi C; Zito F; Voltini F; Reschini E; Gerundini P Med Phys; 2006 Aug; 33(8):2860-7. PubMed ID: 16964862 [TBL] [Abstract][Full Text] [Related]
15. Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma. Luster M; Sherman SI; Skarulis MC; Reynolds JR; Lassmann M; Hänscheid H; Reiners C Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1371-7. PubMed ID: 12856155 [TBL] [Abstract][Full Text] [Related]
16. Iodine prophylaxis and nuclear accidents. Franić Z Arh Hig Rada Toksikol; 1999 Jun; 50(2):223-33. PubMed ID: 10566200 [TBL] [Abstract][Full Text] [Related]
17. A dosimetric approach to patient-specific radioiodine treatment of Graves' disease with incorporation of treatment-induced changes in thyroid mass. Traino AC; Di Martino F; Lazzeri M Med Phys; 2004 Jul; 31(7):2121-7. PubMed ID: 15305466 [TBL] [Abstract][Full Text] [Related]
18. Radiation exposure rate from 131I-treated hyperthyroid patients--a dynamic study, with data for up to 42 d post therapy. Mohammadi H Health Phys; 2005 May; 88(5):486-90. PubMed ID: 15824597 [TBL] [Abstract][Full Text] [Related]
19. Normal organ radiation dosimetry and associated uncertainties in nuclear medicine, with emphasis on iodine-131. Brill AB; Stabin M; Bouville A; Ron E Radiat Res; 2006 Jul; 166(1 Pt 2):128-40. PubMed ID: 16808602 [TBL] [Abstract][Full Text] [Related]
20. Age-dependent potassium iodide effect on the thyroid irradiation by 131I and 133I in the nuclear emergency. Jang M; Kim HK; Choi CW; Kang CS Radiat Prot Dosimetry; 2008; 130(4):499-502. PubMed ID: 18337292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]